37 CFR 1.97 — Filing of information disclosure statement
Ninth Edition, Revision 01.2024
- (a) In order for an applicant for a patent or for a reissue of a patent to have an information disclosure statement in compliance with § 1.98 considered by the Office during the pendency of the application, the information disclosure statement must satisfy one of paragraphs (b), (c), or (d) of this section.
- (b) An information disclosure statement shall be
considered by the Office if filed by the applicant within any one
of the following time periods:
- (1) Within three months of the filing date of a national application other than a continued prosecution application under § 1.53(d) ;
- (2) Within three months of the date of entry of the national stage as set forth in § 1.491 in an international application;
- (3) Before the mailing of a first Office action on the merits;
- (4) Before the mailing of a first Office action after the filing of a request for continued examination under § 1.114 ; or
- (5) Within three months of the date of publication of the international registration under Hague Agreement Article 10(3) in an international design application.
- (c) An information disclosure statement shall be
considered by the Office if filed after the period specified in
paragraph (b) of this section, provided that the information
disclosure statement is filed before the mailing date of any of a
final action under §
1.113
, a notice
of allowance under §
1.311
, or an
action that otherwise closes prosecution in the application, and it
is accompanied by one of:
- (1) The statement specified in paragraph (e) of this section; or
- (2) The fee set forth in § 1.17(p) .
- (d) An information disclosure statement shall be
considered by the Office if filed by the applicant after the period
specified in paragraph (c) of this section, provided that the
information disclosure statement is filed on or before payment of
the issue fee and is accompanied by:
- (1) The statement specified in paragraph (e) of this section; and
- (2) The fee set forth in § 1.17(p) .
- (e) A statement under this section must state
either:
- (1) That each item of information contained in the information disclosure statement was first cited in any communication from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the information disclosure statement; or
- (2) That no item of information contained in the information disclosure statement was cited in a communication from a foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification after making reasonable inquiry, no item of information contained in the information disclosure statement was known to any individual designated in § 1.56(c) more than three months prior to the filing of the information disclosure statement.
- (f) No extensions of time for filing an information disclosure statement are permitted under § 1.136 . If a bona fide attempt is made to comply with § 1.98 , but part of the required content is inadvertently omitted, additional time may be given to enable full compliance.
- (g) An information disclosure statement filed in accordance with this section shall not be construed as a representation that a search has been made.
- (h) The filing of an information disclosure statement
shall not be construed to be an admission that the information
cited in the statement is, or is considered to be, material to
patentability as defined in §
1.56(b)
.
- (i) If an information disclosure statement does not comply with either this section or § 1.98 , it will be placed in the file but will not be considered by the Office.
[48 FR 2696, Jan. 20, 1983, effective date Feb. 27, 1983; 57 FR 2021, Jan. 17, 1992, effective Mar. 16, 1992; para. (d) revised, 60 FR 20195, Apr. 25, 1995, effective June 8, 1995; paras. (a)- (d) revised, 61 FR 42790, Aug. 19, 1996, effective Sept. 23, 1996; paras. (c)-(e) revised, 62 FR 53132, Oct. 10, 1997, effective Dec. 1, 1997; para. (b) revised, 65 FR 14865, Mar. 20, 2000, effective May 29, 2000 (adopted as final, 65 FR 50092, Aug. 16, 2000); paras. (a) through (e) and (i) revised, 65 FR 54604, Sept. 8, 2000, effective Nov. 7, 2000; paras. (b)(3)-(4) revised and para. (b)(5) added, 80 FR 17918, Apr. 2, 2015, effective May 13, 2015]
Cited authority
- 37 CFR 1.98 Content of information disclosure statement
- 37 CFR 1.53 (pre-AIA) Application number, filing date, and completion of application
- 37 CFR 1.491 (pre-AIA) National stage commencement and entry
- 37 CFR 1.114 Request for continued examination
- 37 CFR 1.113 Final rejection or action
- 37 CFR 1.311 Notice of Allowance
- 37 CFR 1.17 Patent application and reexamination processing fees
- 37 CFR 1.56 (pre-AIA) Duty to disclose information material to patentability
- 37 CFR 1.136 Extensions of time
Cited by
- 1206 Amendments and Affidavits or Other Evidence Filed With or After Appeal
- 1207.03(c) Appellant's Reply to New Grounds of Rejection
- 1207.04 Reopening of Prosecution After Appeal
- 1207.05 Substitute Examiner’s Answer
- 1308 Withdrawal From Issue
- 1406 Citation and Consideration of References Cited in Original Patent
- 1418 Notification of Prior/Concurrent Proceedings and Decisions Thereon, and of Information Known To Be Material to Patentability
- 1455 Allowance and Issue
- 1504.04 Considerations Under 35 U.S.C. 112
- 1893.03(g) Information Disclosure Statement in a National Stage Application
- 2001 Duty of Disclosure, Candor, and Good Faith
- 2001.04 Information Under 37 CFR 1.56(a)
- 2003 Disclosure __ When Made
- 2129 Admissions as Prior Art
- 2146.02 Establishing Common Ownership or Joint Research Agreement Under Pre-AIA 35 U.S.C. 103(c)
- 2146.03 Examination Procedure With Respect to Pre-AIA 35 U.S.C. 103(c)
- 2271 Final Action
- 2730 Applications Filed on or After May 29, 2000; Grounds for Adjustment
- 2732 Reduction of Period of Adjustment of Patent Term
- 2920.05(f) Information Disclosure Statement in an International Design Application Designating the United States
- 601 Content of Provisional and Nonprovisional Applications
- 608.01(a) Arrangement of Application
- 608.01(c) Background of the Invention
- 609 Information Disclosure Statement
- 609.01 Examiner Checklist for Information Disclosure Statements
- 609.02 Information Disclosure Statements in Continued Examinations or Continuing Applications
- 609.03 Information Disclosure Statements in National Stage Applications
- 609.04(a) Content Requirements for an Information Disclosure Statement
- 609.04(b) Timing Requirements for an Information Disclosure Statement
- 609.05 Examiner Handling of Information Disclosure Statements
- 609.05(a) Noncomplying Information Disclosure Statements
- 609.05(b) Complying Information Disclosure Statements
- 609.05(c) Documents Submitted as Part of Applicant’s Reply to Office Action
- 609.07 IDSs Electronically Submitted (eIDS) Using Patent Center
- 704.14(a) Format of the Requirement
- 704.14(b) Examiner’s Obligation Following Applicant’s Reply
- 704.14(d) Relationship to Information Disclosure Statements
- 706.07(a) Final Rejection, When Proper on Second Action
- 706.07(g) Transitional After-Final Practice
- 706.07(h) Request for Continued Examination (RCE) Practice
- 707.05 Citation of References
- 708.02(a) Accelerated Examination
- 709 Suspension of Action
- 710.02(c) Specified Time Limits: Situations in Which Used
- 714.16 Amendment After Notice of Allowance, 37 CFR 1.312
- 717.02(a) Invoking the Prior Art Exception under 35 U.S.C. 102(b)(2)(C)
- 717.02(b) Evaluating Whether the Prior Art Exception under AIA 35 U.S.C. 102(b)(2)(C) is Properly Invoked
- 717.02(c) Examination Procedure With Respect to the Prior Art Exception under AIA 35 U.S.C. 102(b)(2)(C)
- 719.05 Field of Search
- 803.02 Election of Species Requirements – Markush Claims
- 804 Definition of Double Patenting
- 821.04 Rejoinder
- 37 CFR 1.17 Patent application and reexamination processing fees
- 37 CFR 1.51 General requisites of an application
- 37 CFR 1.56 Duty to disclose information material to patentability
- 37 CFR 1.98 Content of information disclosure statement
- 37 CFR 1.704 Reduction of period of adjustment of patent term